Taurine Attenuates Hepatic Inflammation in Chronic Alcohol-Fed Rats Through Inhibition of TLR4/MyD88 Signaling

Journal of Medicinal Food

Volumn 18, Issue 12, 2015, Pages 1291-1298

  Lin, Chao Jen ^a   Chiu, Chun Ching ^a,b   Chen, Yi Chen ^c   Chen, Mu Lin ^b   Hsu, Tsai Ching ^b,d   Tzang, Bor Show ^b,d  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chronic alcohol fed rats; Hepatic injury; Inflammation; Silymarin; Taurine

Indexed keywords

ALCOHOL; C REACTIVE PROTEIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; SILYMARIN; SYNAPTOTAGMIN I; TAURINE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; INTERLEUKIN DERIVATIVE; NOS2 PROTEIN, RAT; TLR4 PROTEIN, RAT;

ALCOHOL CONSUMPTION; ALCOHOL INDUCED HEPATIC INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; LIVER INJURY; LIVER PROTECTION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CHEMICAL AND DRUG INDUCED LIVER INJURY; CHEMICALLY INDUCED; COMPLICATION; INFLAMMATION; LYMPHOCYTE; MALE; METABOLISM; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; C-REACTIVE PROTEIN; CHEMICAL AND DRUG INDUCED LIVER INJURY; ETHANOL; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKINS; LYMPHOCYTES; MALE; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RATS, WISTAR; SIGNAL TRANSDUCTION; SILYMARIN; TAURINE; TOLL-LIKE RECEPTOR 4;

EID: 84952655667     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2014.3408     Document Type: Article

References (45)

1. Regimbeau JM, Abdalla EK, Vauthey JN, et al.: Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: Results of a multicenter study. J Surg Oncol 2004;85:36-41.
2. O'Shea RS, Dasarathy S, McCullough AJ; Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology: Alcoholic liver disease. Hepatology 2010;51:307-328.
3. Albano E: Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 2006;65:278-290.
4. Zakhari S: Overview: How is alcohol metabolized by the body? Alcohol Res Health 2006;29:245-254.
5. Nei J, Matsuda Y, Takada A: Chronic hepatitis induced by alcohol. Dig Dis Sci 1983;28:207-215.
6. Tsukamoto H, Towner SJ, Ciofalo LM, French SW: Ethanolinduced liver fibrosis in rats fed high fat diet. Hepatology 1986;6:814-822.
7. Tien Kuo M, Savaraj N: Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers. Mol Carcinog 2006;45:701-709.
8. Bruck R, Aeed H, AvniI Y, et al.: Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects against thioacetamide induced liver damage in mice. J Hepatol 2004;40:86-93.
9. Schopen RD, Lange OK: Therapy of hepatoses. Therapeutic use of silymarin. Med Welt 1970;15:691-698.
10. Platt D, Schnorr B: Biochemical and electronoptic study on the possible effect of silymarin on ethanol-induced liver damage in rats. Arzneimittelforschung 1971;21:1206-1208.
11. Lieber CS, Leo MA, Cao Q, Ren C, DeCarli LM: Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J Clin Gastroenterol 2003;37:336-339.
12. Fehér J, Lengyel G: Silymarin in the treatment of chronic liver diseases: Past and future. Orv Hetil 2008;149:2413-2418.
13. Hanje AJ, Fortune B, Song M, Hill D, Hill D, McClain C: The use of selected nutrition supplements and complementary and alternative medicine in liver disease. Nutr Clin Pract 2006;21: 255-272.
14. Lee JY, Jung DW, Park HA, et al.: Effect of taurine on biliary excretion and metabolism of acetaminophen in male hamsters. Biol Pharm Bull 2004;27:1792-1796.
15. Bouckenooghe T, Remacle C, Reusens B: Is taurine a functional nutrient? Curr Opin Clin Nutr Metab Care 2006;9:728-733.
16. Edgar SE, Kirk CA, Rogers QR, Morris JG: Taurine status in cats is not maintained by dietary cysteinesulfinic acid. J Nutr 1998; 128:751-757.
17. Kadam SU, Prabhasankar P: Marine foods as functional ingredients in bakery and pasta products. Food Res Int 2010;43:1975-1980.
18. Bidri M, Choay P: Taurine: A particular aminoacid with multiple functions. Ann Pharm Fr 2003;61:385-391.
19. Chou CH, Chang YY, Tzang BS, et al.: Effects of taurine on hepatic lipid metabolism and anti-inflammation in chronic alcohol-fed rats. Food Chem 2012;135:24-30.
20. Wu MT, Tzang BS, Chang YY, et al.: Effects of Antrodia camphorata on alcohol clearance and antifibrosis in livers of rats continuously fed alcohol. J Agric Food Chem 2011;59:4248-4254.
21. Hsu TC, Tsai CC, Chiu CC, Hsu JD, Hsu JD, Tzang BS: Exacerbating effects of human parvovirus B19 NS1 on liver fibrosis in NZB/W F1 mice. PLoS One 2013;8:e68393.
22. Huang CY, Hsu TC, Kuo WW, et al.: Beneficial effects of taurine on cardiac abnormality in NZB/W F1 mice fed with a highcholesterol diet. J Agric Food Chem 2009;57:8635-8642.
23. Hsu TC, Chiu CC, Wang YW, Tzang BS: Effects of cystamine on antioxidant activities and regulatory T cells in lupus-prone mice. J Cell Mol Med 2013;17:1308-1315.
24. Chesney RW: Taurine: Its biological role and clinical implications. Adv Pediatr 1985;32:1-42.
25. Huxtable RJ: Physiological actions of taurine. Physiol Rev 1992;72:101-163.
26. Redmond HP, Wang JH, Bouchier-Hayes D: Taurine attenuates nitric oxide-and reactive oxygen intermediate-dependent hepatocyte injury. Arch Surg 1996;131:1280-1287.
27. Grimble RF: Sulphur amino acids and the metabolic response to cytokines. Adv Exp Med Biol 1994;359:41-49.
28. Kontny E, Szczepanska K, Kowalczewski J, et al.: The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 2000;43:2169-2177.
29. Chorazy M, Kontny E, Marcinkiewicz J, Maslinski W: Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells. Amino Acids 2002;23:407-413.
30. Wu G, Yang J, Sun C, Luan X, Shi J, Hu J: Effect of taurine on alcoholic liver disease in rats. Amino Acids 2009;36:457-464.
31. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003;21:335-376.
32. Roh YS, Seki E: Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol 2013;28:38-42.
33. Szabo G, Petrasek J, Bala S: Innate immunity and alcoholic liver disease. Dig Dis 2012;30:55-60.
34. Fujimoto M, Uemura M, Kojima H, et al.: Prognostic factors in severe alcoholic liver injury. Nara Liver Study Group. Alcohol Clin Exp Res 1999;23:33S-38S.
35. Deng XS, Deitrich RA: Ethanol metabolism and effects: Nitric oxide and its interaction. Curr Clin Pharmacol 2007;2:145-153.
36. Thompson D, Pepys M, Wood S: The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 1999;7:169-177.
37. Pepys M, Hirschfield G: C-reactive protein: A critical update. J Clin Invest 2003;111:1805-1812.
38. Darke S, Duflou J, Torok M, Prolov T: Characteristics, circumstances and toxicology of sudden or unnatural deaths involving very high range alcohol concentrations. Addiction 2013;108: 1411-1417.
39. French SW, Vitocruz E, French BA: Balloon liver cells forming Mallory-Denkbodies are progenitor cells. Exp Mol Pathol 2013; 95:117-120.
40. Ishak KG, Zimmerman HJ, Ray MB: Alcoholic liver disease: Pathologic, pathogenetic and clinical aspects. Alcohol Clin Exp Res 1991;15:45-66.
41. Jensen K, Gluud C: The Mallory body: Morphological, clinical and experimental studies (Part 1 of a literature survey). Hepatology 1994;20:1061-1077.
42. Oliva J, Bardag-Gorce F, Lin A, French BA, French SW: The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes. Exp Mol Pathol 2010;89:1-8.
43. Neuman MG: Cytokines-central factors in alcoholic liver disease. Alcohol Res Health 2003;27:307-316.
44. Gong P, Canaan A, Wang B, et al.: The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J Am Soc Nephrol 2010;21:316-326.
45. Cheng KC, Asakawa A, Li YX, et al.: Silymarin induces insulin resistance through an increase of phosphatase and tensin homolog in Wistar rats. PLoS One 2014;9:e84550.